glycyrrhizic acid has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, H; Hostetler, BJ; McKallip, RJ; Uchakina, ON | 1 |
1 other study(ies) available for glycyrrhizic acid and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Treatment of Hematological Malignancies with Glycyrrhizic Acid.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Glycyrrhizic Acid; Hematologic Neoplasms; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytes, Mononuclear; Lymphoma; Mice; Neoplasm Transplantation; Reactive Oxygen Species | 2017 |